Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Business & Regulation Business Practice

Let’s Talk About Mental Health

| Roisin McGuigan

A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups

Business & Regulation Business Practice

Knowing Your Values

| Stephanie Sutton

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

Business & Regulation Business Practice

For Patients, Not Profits

A new not-for-profit company will manufacture important generics in the US

Manufacture Business Practice

Nanoformulations: Reach for the (Micro)Sun!

| James Strachan

The UK’s Centre for Process Innovation targets easier manufacturing of nanoformulated medicines.

Business & Regulation Business Practice

Just Can’t Get the Staff!

| James Strachan

Which biopharma positions are hardest to fill? What skills are most in demand? And what can companies do to ensure they discover and nurture talent?

Business & Regulation Business Practice

Business-in-Brief

| James Strachan

First-of-its-kind Parkinson’s trial, Brexit woes, and a vaccine scandal in China… What’s new for pharma in business?

Business & Regulation Business Practice

MAICing a Decision

| James Strachan

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Business & Regulation Business Practice

Brexit: Preparing Is Caring

| James Strachan

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Discovery & Development Business Practice

In Conversation with Christophe Le Ret of Umicore Precious Metals Chemistry at CPhI 2017

Here, James speaks with Christophe Le Ret from Umicore.

Discovery & Development Business Practice

In Conversation with Michel Lagarde from Patheon part of Thermo Fisher Scientific at CPhI 2017

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register